TrialNature communications2026

Tremelimumab with or without durvalumab in combination with paclitaxel in metastatic urothelial cancer: phase I/II ICRA trial.

Sarah M H Einerhand et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.